182 related articles for article (PubMed ID: 37935889)
21. Risk Factors of Early Allograft Dysfunction in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure After Deceased Donor Liver Transplant.
Yi J; Zhou Z; Li Q; Chen G; He Z; Ma Y; Luo X; Si Z; Li J
Exp Clin Transplant; 2022 Jul; 20(7):668-673. PubMed ID: 35924745
[TBL] [Abstract][Full Text] [Related]
22. The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease.
Younossi ZM; Stepanova M; Al Shabeeb R; Eberly KE; Shah D; Nguyen V; Ong J; Henry L; Alqahtani SA
Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38126928
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C Virus Eradication with New Interferon-Free Treatment Improves Metabolic Profile in Hepatitis C Virus-Related Liver Transplant Recipients.
Beig J; Orr D; Harrison B; Gane E
Liver Transpl; 2018 Aug; 24(8):1031-1039. PubMed ID: 29577581
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.
Hoffmann CJ; Subramanian AK; Cameron AM; Engels EA
Transplantation; 2008 Sep; 86(6):784-90. PubMed ID: 18813102
[TBL] [Abstract][Full Text] [Related]
25. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
26. Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.
Yang T; Hu LY; Li ZL; Liu K; Wu H; Xing H; Lau WY; Pawlik TM; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Li C; Wang MD; Wu MC; Shen F
J Gastrointest Surg; 2020 Feb; 24(2):320-329. PubMed ID: 30617773
[TBL] [Abstract][Full Text] [Related]
27. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Hepatitis B and C Among Liver Transplant Recipients With Hepatocellular Carcinoma: An Analysis of the Nationwide Inpatient Sample Database.
Lam PH; Obirieze AC; Ortega G; Nwokeabia I; Onyewu S; Purnell SD; Samimi MM; Weeks CB; Lee EL; Shokrani B; Frederick WA; Callender CO; Wilson LL
Transplant Proc; 2016; 48(1):123-7. PubMed ID: 26915856
[TBL] [Abstract][Full Text] [Related]
29. Resection of hepatocellular carcinoma without cirrhosis.
Shrager B; Jibara G; Schwartz M; Roayaie S
Ann Surg; 2012 Jun; 255(6):1135-43. PubMed ID: 22258064
[TBL] [Abstract][Full Text] [Related]
30. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
[TBL] [Abstract][Full Text] [Related]
31. Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.
Zarrinpar A; Faltermeier CM; Agopian VG; Naini BV; Harlander-Locke MP; Kaldas FM; Farmer DG; Busuttil RW
Liver Int; 2019 Mar; 39(3):531-539. PubMed ID: 30427105
[TBL] [Abstract][Full Text] [Related]
32. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY
J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391
[TBL] [Abstract][Full Text] [Related]
34. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.
Chan AW; Wong GL; Chan HY; Tong JH; Yu YH; Choi PC; Chan HL; To KF; Wong VW
J Gastroenterol Hepatol; 2017 Mar; 32(3):667-676. PubMed ID: 27547913
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with recurrence and survival in liver transplant patients with HCC--a single center retrospective study.
Hoyos S; Escobar J; Cardona D; Guzmán C; Mena Á; Osorio G; Pérez C; Restrepo JC; Correa G
Ann Hepatol; 2015; 14(1):58-63. PubMed ID: 25536642
[TBL] [Abstract][Full Text] [Related]
36. [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease].
Kwon OS; Kim JH; Kim JH
Korean J Gastroenterol; 2017 Jun; 69(6):348-352. PubMed ID: 28637103
[TBL] [Abstract][Full Text] [Related]
37. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Outcomes of Living Donor Versus Deceased Donor Liver Transplant for Hepatocellular Carcinoma in the United States.
Muhammad H; Gurakar M; Ting PS; Alsughayer AM; Luu H; Zaffar D; Alqahtani S; Bonder A; Gurakar A; Saberi B
Exp Clin Transplant; 2022 Mar; 20(3):279-284. PubMed ID: 35352634
[TBL] [Abstract][Full Text] [Related]
39. Descriptive Analysis of Everolimus Conversion in Liver Transplant Recipients With Malignant Neoplastic Disease.
Nogueras López F; Espinosa Aguilar MD; Abellán Alfocea P; Ortega Suazo EJ; González Sánchez M; Redondo Cerezo E; López Garrido MA
Transplant Proc; 2020 Mar; 52(2):553-555. PubMed ID: 32035682
[TBL] [Abstract][Full Text] [Related]
40. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.
Younossi ZM; Stepanova M; Saab S; Ahmed A; Lam B; Srishord M; Venkatesan C; Wai H; Henry L
J Viral Hepat; 2016 Jan; 23(1):53-61. PubMed ID: 26289820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
